VideaHealth Dental AI: FDA-Cleared Platform Explained

VideaHealth dental AI is an FDA-cleared, multi-algorithm platform built for diagnostic assistance, workflow automation, and practice analytics. Founded in 2018 out of Harvard and MIT research, the Boston-based company has grown into one of the most widely deployed dental AI solutions in North America, with more than 90,000 clinicians using it across 60-plus DSOs, according to vendor-reported figures.

Here’s what practice owners and clinical leaders actually need to know.

What VideaHealth Is — and What It Isn’t

VideaAI positions itself as a comprehensive assistant covering diagnostics, workflows, and revenue analytics. That’s a broader scope than many point solutions. But the core product — and the one with the deepest independent validation — is its radiograph analysis suite.

The platform integrates directly into existing clinical systems and overlays findings on X-rays in real time, chairside. It’s designed to support, not supplant, the clinician. The AI flags; the dentist decides. That distinction matters both clinically and regulatorily.

FDA Clearances: What’s Actually Cleared

This is where VideaHealth separates itself from the crowded field of dental AI startups. The company holds three distinct 510(k) clearances from the FDA:

Videa Caries Assist was the first clearance, covering AI-powered cavity detection on radiographs. In the FDA trial, dentists using the tool missed 43% fewer caries and reduced erroneous detections by 15% on average — with gains seen across all experience levels, per FDA trial performance data reported by the company.

Videa Dental Assist expanded coverage to more than 30 algorithms, including periapical radiolucencies, calculus, and pediatric caries detection for children aged three and older. That last one is notable: it’s the first pediatric radiology AI clearance issued in dentistry by any regulatory agency worldwide, according to VideaHealth.

Videa Perio Assist adds alveolar bone level measurement. In bench testing, it met pre-specified acceptance criteria on periapical radiographs with a recall of 91.9%, per manufacturer-reported data.

The algorithms were trained and tested on bitewing, periapical, and panoramic radiographs — all three of the standard radiograph types used in general practice.

For context on how this regulatory picture compares to competitors, see our breakdown of overjet dental ai and pearl ai dental.

DSO Scale: Real-World Deployments

The clinical data is one thing. The operational track record is another, and VideaHealth’s here is genuinely large.

Heartland Dental rolled out VideaAI across its entire supported network — the largest dental AI implementation by that measure at the time — in under 10 weeks, according to DrBicuspid. Great Expressions Dental Centers deployed it enterprise-wide across more than 210 practices in two weeks. Aspen Dental completed a full-network rollout and reported a 12% lift in patients accepting recommended care in pilot offices, though that figure comes from vendor-reported case study data and should be read as such.

The Aspen relationship runs deep: the DSO’s chairman and chief clinical officer both sit on VideaHealth’s AI Leadership Council.

VideaAI is also embedded in Henry Schein One’s platforms as co-branded Dentrix Detect AI and Dentrix Ascend AI — which matters for independent practices that would never go through a DSO procurement process.

Beyond Diagnostics: The Broader Platform

VideaHealth has expanded well past X-ray overlays. A few modules worth knowing:

• OrthoAI and ImplantAI analyze routine radiographs to surface patients likely to benefit from aligners or implants. A vendor-reported pilot showed a 14% increase in aligner treatments planned within 30 days of deployment, translating to an estimated $125,000 in additional revenue per location, per the manufacturer’s own data. Treat those numbers as directional rather than assured outcomes.
• ClaimsAI targets dental revenue cycle management, addressing what VideaHealth describes as $15 billion in industry-wide waste. Details on payer integrations and accuracy rates aren’t yet widely published.
• VideaInsights benchmarks individual provider performance against AI-identified opportunities — useful for group practices managing consistency across sites.
• Voice Notes, still in the pipeline, is described as dentistry’s first ambient AI scribe for chairside documentation.

Where the Platform Fits Best

For a single-location private practice, VideaAI may be more platform than you need. The diagnostic modules are genuinely valuable, but much of the analytics and benchmarking infrastructure is built for group practice and DSO oversight. If you’re running three or fewer locations without a clinical director role, tools like VideaInsights add administrative weight before they add clinical value.

For DSOs and larger groups, the case is stronger — especially given the validated diagnostic performance data and the Henry Schein One integration that reduces implementation friction.

The honest trade-off: VideaHealth’s regulatory credibility and scale are real advantages. The breadth of the platform also means there’s more to configure, train staff on, and maintain than with a narrower point solution. A thorough evaluation using our dental ai software buyer’s guide is worth doing before committing.

If your practice is already on Dentrix, the Dentrix Detect AI co-brand is the lowest-friction entry point. Start there, evaluate diagnostic adoption, and consider the broader suite once you have real utilization data from your own clinicians.